Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.
The complement system membrane cofactor protein (MCP) CD46 serves as a C3b/C4b inactivating factor for the protection of host cells from autologous complement attack and as a receptor for measles virus (MV). MCP consists of four short consensus repeats (SCR) which are the predominant extracellular structural motif. In the present study, we determined which of the four SCR of MCP contribute to its function using Chinese hamster ovary cell clones expressing each SCR deletion mutants. The results were as follows: 1) SCR1 and SCR2 are mainly involved in MV binding and infection; 2) SCR2, SCR3, and SCR4 contribute to protect Chinese hamster ovary cells from human alternative complement pathway-mediated cytolysis; and 3) SCR2 and SCR3 are essential for protection of host cells from the classical complement pathway. These results on cell protective activity of the mutants against the human classical and the alternative complement pathways were compatible with factor I-mediated inactivation profiles of C4b and C3b, respectively, in the fluid-phase assay using solubilized mutants and factor I; the results were mostly consistent with those reported by Adams et al. (Adams, E. M., Brown, M. C., Nunge, M., Krych, M., and Atkinson, J. P. (1991) J. Immunol. 147, 3005-3011). SCR2 and SCR3 were required for C3b and C4b inactivation, and SCR4-deleted MCP showed weak cofactor activity for C4b cleavage but virtually no cofactor activity for C3b cleavage. The functional domains of MCP for the three natural ligands C3b, C4b, and MV, therefore, map to different, although partly overlapping, SCR domains.
Iwata
K
K
Division of Hygienic Chemistry, Hokkaido University, Sapporo, Japan.
Seya
T
T
Yanagi
Y
Y
Pesando
J M
JM
Johnson
P M
PM
Okabe
M
M
Ueda
S
S
Ariga
H
H
Nagasawa
S
S
D000818:Animals; D000911:Antibodies, Monoclonal; D015703:Antigens, CD / Q000235:genetics / Q000502:physiology*; D001483:Base Sequence; D016466:CHO Cells; D003179:Complement C3b / Q000378:metabolism*; D003180:Complement C3b Inactivator Proteins; D015935:Complement C4b / Q000037:antagonists & inhibitors*; D003170:Complement Pathway, Alternative; D003171:Complement Pathway, Classical; D016384:Consensus Sequence; D006224:Cricetinae; D018076:DNA, Complementary; D000939:Epitopes / Q000032:analysis; D014644:Genetic Variation; D006801:Humans; D008459:Measles virus / Q000502:physiology; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000235:genetics / Q000502:physiology*; D008969:Molecular Sequence Data; D016296:Mutagenesis; D009838:Oligodeoxyribonucleotides; D011991:Receptors, Virus / Q000235:genetics / Q000502:physiology*; D011994:Recombinant Proteins / Q000378:metabolism; D012091:Repetitive Sequences, Nucleic Acid; D017384:Sequence Deletion; D014162:Transfection
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; C497857:CD46 protein, human; D003180:Complement C3b Inactivator Proteins; D018076:DNA, Complementary; D000939:Epitopes; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; D009838:Oligodeoxyribonucleotides; D011991:Receptors, Virus; D011994:Recombinant Proteins; D003179:Complement C3b; D015935:Complement C4b